NAC1 Polyclonal Antibody, PE-Cy5.5 Conjugated, PE/Cy5.5, Rabbit

Artikelnummer: BSS-BS-12247R-PE-CY5.5
Artikelname: NAC1 Polyclonal Antibody, PE-Cy5.5 Conjugated, PE/Cy5.5, Rabbit
Artikelnummer: BSS-BS-12247R-PE-CY5.5
Hersteller Artikelnummer: bs-12247R-PE-Cy5.5
Alternativnummer: BSS-BS-12247R-PE-CY5.5-100
Hersteller: Bioss
Wirt: Rabbit
Kategorie: Antikörper
Applikation: WB
Spezies Reaktivität: Rat
Konjugation: PE/Cy5.5
Alternative Synonym: BEND8, BTB Domain Containing 14B, BTB/POZ domain-containing protein 14B, btbd14b, btbd14b, FLJ37383, NAC-1, NAC1, Nacc1, NACC1_HUMAN, Nucleus accumbens-associated protein 1.
NAC1 is an N-terminal homodimerization domain that contains multiple copies of kelch repeats and/or C2H2-type zinc fingers. Proteins that contain BTB domains are thought to be involved in transcriptional regulation via control of chromatin structure and function. BTBD14B (BTB/POZ domain-containing protein 14B), also known as NACC1 (nucleus accumbens associated 1), BEND8 or NAC1, is a 527 amino acid protein that localizes to both the nucleus and the cytoplasm and contains one BTB (POZ) domain. Existing as a homooligomer that interacts with HDAC3 and HDAC4, BTBD14B functions as a transcriptional repressor that influences the transcriptional activity of CRIF1 and is required for proteasome recruitment to the nucleus and cytoplasm in dendritic spines. BTBD14B is overexpressed in multiple carcinomas, suggesting a role in tumor development and metastasis.
Klonalität: Polyclonal
Konzentration: 1ug/ul
NCBI: 112939
Puffer: Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Quelle: KLH conjugated synthetic peptide derived from human NAC1/BTBD14B
Target-Kategorie: NAC1
Application Verdünnung: WB(1:300-5000)